E-LIB Suche - Ergebnisse für: Vlahovic, Gordana

1

CTIM-10. REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGE..:

Batich, Kristen ; Mitchell, Duane ; Healy, Patrick...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi51-vi51 , 2021

2

IMMU-06. TARGETING IDH1 MUTANT GRADE II RECURRENT GLIOMAS U..:

Mohan, Aditya ; Peters, Katherine ; Hotchkiss, Kelly...
Neuro-Oncology Advances. 3 (2021) Supplement_4 - p. iv5-iv6 , 2021

Link: https://doi.org/10.1093/..

3

Tolerability and efficacy of durvalumab in Japanese patient..:

Fujiwara, Yutaka ; Iguchi, Haruo ; Yamamoto, Noboru...
Cancer Science. 110 (2019) 5 - p. 1715-1723 , 2019

Link: https://doi.org/10.1111/..

4

ATIM-31. SAFETY OF TUMOR-SPECIFIC PEPTIDE VACCINE TARGETING..:

Peters, Katherine ; Congdon, Kendra ; Archer, Gary...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi8-vi8 , 2019

Link: https://doi.org/10.1093/..

5

Geospatial Intelligence Workforce Development in a Changing..:

MALHOTRA, RAKESH ; KANTOR, CAMELIA ; VLAHOVIC, GORDANA
Southeastern Geographer. 58 (2018) 1 - p. 125-135 , 2018

Link: https://www.jstor.org/st..

6

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) ..:

Vlahovic, Gordana ; Meadows, Kellen L. ; Hatch, Ace J....
The Oncologist. 23 (2018) 7 - p. 782-790 , 2018

Link: https://doi.org/10.1634/..

7

Phase II Study to Evaluate the Efficacy and Safety of Rilot..:

Affronti, Mary Lou ; Jackman, Jennifer Gamboa ; McSherry, Frances...
The Oncologist. 23 (2018) 8 - p. 889-e98 , 2018

Link: https://doi.org/10.1634/..

8

A cross sectional analysis from a single institution's expe..:

Randazzo, Dina M. ; McSherry, Frances ; Herndon II, James E....
Journal of Neuro-Oncology. 134 (2017) 2 - p. 363-369 , 2017

Link: https://doi.org/10.1007/..

9

Nivolumab with or without ipilimumab in patients with recur..:

Omuro, Antonio ; Vlahovic, Gordana ; Lim, Michael...
Neuro-Oncology. 20 (2017) 5 - p. 674-686 , 2017

Link: https://doi.org/10.1093/..

10

Tumor stem cell RNA-loaded dendritic cell vaccine for recur..:

Dunn-Pirio, Anastasie ; Peters, Katherine ; DesJardins, Annick...
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

11

QLIF-34. PILOT STUDY TO DESCRIBE THE TRAJECTORY OF SYMPTOMS..:

Affronti, Mary Lou ; Randazzo, Dina ; Peters, Katherine B...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi208-vi209 , 2017

Link: https://doi.org/10.1093/..

12

Prognostic Importance of Brain Tumor Specific Health-Relate..:

Peters, Katherine ; Affronti, Mary Lou ; Lipp, Eric...
Neurology. 88 (2017) 16_supplement - p. , 2017

Link: https://doi.org/10.1212/..

13

QLIF-20. A CROSS-SECTIONAL STUDY OF DISTRESS THROUGHOUT THE..:

Randazzo, Dina ; McSherry, Frances ; Herndon, James...
Neuro-Oncology. 18 (2016) suppl_6 - p. vi160-vi160 , 2016

Link: https://doi.org/10.1093/..

14

The upper crust of the Eastern Tennessee Seismic Zone: Insi..:

Brandmayr, Enrico ; Vlahovic, Gordana
Tectonophysics. 685 (2016) - p. 1-7 , 2016

Link: https://doi.org/10.1016/..

15

ATIM-18. PHASE I DOSE ESCALATION STUDY OF D2C7-IT ADMINISTE..:

Desjardins, Annick ; Randazzo, Dina ; Chandramohan, Vidya...
Neuro-Oncology. 18 (2016) suppl_6 - p. vi21-vi22 , 2016

Link: https://doi.org/10.1093/..